Skip to content

The Effect of Protein Ingestion on the Recovery of Skeletal Muscle Function Following Eccentric Exercise.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02980900
Acronym
SPADE
Enrollment
36
Registered
2016-12-02
Start date
2017-01-01
Completion date
2018-08-01
Last updated
2018-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy

Brief summary

The present study will assess the effect of the type and timing of protein ingestion 6 days prior to, and 7 days following eccentric exercise on the time course of 1) the recovery of muscle function, 2) the recovery of perceived muscle soreness, 3) muscle metabolism.

Interventions

DIETARY_SUPPLEMENTPost exercise protein-polyphenol supplement

Participants will ingest a post exercise protein-polyphenol supplement. This will begin 6 days before eccentric exercise and will end 6 days after eccentric exercise.

DIETARY_SUPPLEMENTPost exercise placebo supplement

Participants will ingest an isocaloric placebo supplement after exercise. This will begin 6 days before eccentric exercise and will end 6 days after eccentric exercise.

DIETARY_SUPPLEMENTPre bed protein-polyphenol supplement

Participants will ingest a protein-polyphenol supplement before bed. This will begin 6 days before eccentric exercise and will end 6 days after eccentric exercise.

DIETARY_SUPPLEMENTPre bed placebo supplement

Participants will ingest an isocaloric placebo supplement before bed. This will begin 6 days before eccentric exercise and will end 6 days after eccentric exercise.

Sponsors

University of Exeter
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 35 Years
Healthy volunteers
Yes

Inclusion criteria

* Men and women who are generally healthy and recreationally active

Exclusion criteria

* Active cardiovascular disease or hypertension * Diagnosed metabolic impairment * Use of nutritional supplements * Use of anti-inflammatory medications * Habitual dietary protein intake of \<0.8g/kg/day * Musculoskeletal disorders

Design outcomes

Primary

MeasureTime frame
Isokinetic force production of the knee extensor muscles14 days

Secondary

MeasureTime frame
Muscle protein synthesis14 days
Thigh volume14 days
Perceived muscle soreness14 days
Isometric force production of the knee extensor muscles14 days

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026